Pierre Sujobert

12PUBLICATIONS
113CO-AUTHORS
Behavioural epidemiologyHaematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 19, 2025
Epstein-Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways.

Susanne Delecluse, Francesco Baccianti, Manon Zala

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Apr 24, 2025
Myeloid neoplasms after CD19-directed CAR T cells therapy in long-term B-cell lymphoma responders, a rising risk over time?

Nicolas Gazeau, David Beauvais, Rémi Tilmont

|Apr 03, 2023
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.

Marie Sabatier, Rudy Birsen, Laura Lauture

|Nov 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.

Lorric Delage, Mireille Lambert, Émilie Bardel

|Aug 04, 2020
Commercial anti-CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center.

Pierre Sesques, Emmanuelle Ferrant, Violaine Safar

Pageof 2

Frequent Collaborators

2 joint publications

Audrey Bidet

2 joint publications

Pascale Flandrin-Gresta

2 joint publications

Cédric Pastoret

2 joint publications

Yannick Le Bris